Power 3 Medical Products, Inc. operates in the Commercial physical research sector. Power3 Medical Products, Inc. (Power3) is a biotechnology company focused on the development and marketing of diagnostic products through the analysis of proteins. It is focused on the development of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases, such as amytrophic lateral sclerosis (ALS) (also known as Lou Gehrig's disease), Alzheimer's disease and Parkinson's disease. It also addresses clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others through collaborations with academic and research institutions. Power3 applies its methodologies to discover and identify protein biomarkers associated with diseases. It has developed a portfolio of products, including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer, and NuroPro, a serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases. In our complete report available for purchase the company is compared to: Senesco Technologies, Inc., Bioheart, Incorporation and Medicago Incorporation.